Quantcast
Home > Quotes > AXLA

Axcella Health Inc. Common Stock (AXLA) Quote & Summary Data

AXLA 
$5.21
*  
0.03
0.57%
Get AXLA Alerts
*Delayed - data as of Jan. 28, 2020  -  Find a broker to begin trading AXLA now
Exchange:NASDAQ
Industry: Health Care
View:    AXLA Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 5.46 / $ 5.16
Share Volume
39,374
50 Day Avg. Daily Volume
81,769
Previous Close
$ 5.24
52 Week High / Low
$ 15.99 / $ 2.76
Market Cap
120,422,455
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
39,374
50 Day Avg. Daily Volume:
81,769

Trading Range

The current last sale of $5.21 is 88.77% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 5.46 $ 15.99
 Low: $ 5.16 $ 2.76

Company Description (as filed with the SEC)

We are a biotechnology company pioneering the research and development of novel multifactorial interventions to support health and address dysregulated metabolism across a broad spectrum of consumers and patients who have limited options. Our AXA Candidates are generated from our proprietary, human-focused AXA Development Platform and harness the power of endogenous metabolic modulators, or EMMs, a broad family of molecules that fundamentally impact and regulate human metabolism. Using our AXA Development Platform, we have rapidly generated a pipeline of AXA Candidates that are novel compositions of EMMs engineered in distinct ratios and designed to target and maximize the fundamental role that EMMs play in regulating multiple metabolic functions. Our AXA Candidates are administered orally and anchored by amino acids, which have a history of safe use as food. As such, we expect our AXA Candidates may also be combinable with other modalities.  ... More ...  



Risk Grade

Where does AXLA fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 5.33
Open Date:
Jan. 28, 2020
Close Price:
$ 5.21
Close Date:
Jan. 28, 2020


Consensus Recommendation

Analyst Info